Jo Parkes, Lead Clinical Pharmacist – Cancer Services and Advanced Clinical Practice at , shared a post on LinkedIn by The Immunobuddies Podcast, adding:
“What happens when you bring three oncologists, a pharmacist, and a microphone together to talk about subcutaneous immunotherapy?
A lot of insight, debate, and pharmacokinetics – a pharmacist’s dream conversation.
I had the pleasure of joining The Immunobuddies Podcast with Dr Ricky Frazer, Dr Anna Olsson-Brown, and Dr Vasiliki Michalarea to explore the clinical potential of SC immunotherapy, its impact on patients, and the logistical challenges of integrating it into routine NHS practice.
An engaging conversation about what’s exciting, what’s challenging, and what this shift could mean for oncology services and pharmacy teams.
Catch Part 1 here
Part 2 coming soon…”
Quoting The Immunobuddies Podcast‘s post:
“NEW EPISODE OUT NOW!
Is Subcutaneous Immunotherapy a Game-Changer or Just Hype?
Join Ricky Frazer and Dr Anna Olsson-Brown as they unpack the science, promise and pitfalls of Subcutaneous Immunotherapy with special guests Jo Parkes and Dr Vasiliki Michalarea.
We’re diving into:
- The role of Subcutaneous Immunotherapy in cancer
- Real-world logistics and patient selection
- Innovations redefining injectable immune treatments
- Is it the future – or just a fad?
Don’t miss this bold conversation on Episode 151 of The Immunobuddies!
Listen now”
More posts featuring Immunotherapy on OncoDaily.